# FDA Inspection 1225221 - BioReliance Limited - November 07, 2023

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-limited/e278d24d-048b-4de1-923a-1d89674fcba2
Source feed: FDA_Inspections

> FDA Inspection 1225221 for BioReliance Limited on November 07, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225221
- Company Name: BioReliance Limited
- Inspection Date: 2023-11-07
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1091242 - 2019-03-21](https://www.keypedia.com/records/fda_inspections/bioreliance-limited/41409e45-b136-4af0-ba96-4519b2e71f8d)
- [FDA Inspection 989581 - 2016-09-07](https://www.keypedia.com/records/fda_inspections/bioreliance-limited/5fdf45e6-3fe7-4e24-8431-920834d420d4)
- [FDA Inspection 976630 - 2016-03-17](https://www.keypedia.com/records/fda_inspections/bioreliance-limited/8bc09302-521d-4cd0-bfd7-e682a99200b1)
- [FDA Inspection 890483 - 2014-07-23](https://www.keypedia.com/records/fda_inspections/bioreliance-limited/bc78e717-8ad1-4e69-a94f-8456eeb71bd0)

Company: https://www.keypedia.com/companies/bioreliance-limited/0f9685fe-7747-40e3-b058-88035ca34e4a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d